Pressmeddelande -
Delphi advisor to Ardena in the acquisition of Syntagon Invest AB
Delphi has advised the Ardena group (Ardena) in the acquisition of Syntagon Invest AB and its subsidiaries Syntagon AB and Syntagon Baltic (jointly referred to as Syntagon).
Syntagon was established in 1999 and has sites in Sweden and Latvia with approximately 30 employees. Syntagon offers a comprehensive development package for Life Science ingredients and GMP manufacturing from early development to commercial manufacturing.
Ardena is a portfolio company of Mentha Capital and was formed in 2017, following the merging of three companies with complementary capabilities: Pharmavize in Belgium, Crystallics and Analytical Biochemical Laboratory (ABL) in the Netherlands. After the acquisitions of Syntagon and ChemConnection in 2018, Ardena now employs more than 225 scientists.
Delphi’s team mainly consisted of Fredrik Mörner (responsible partner) and Linn Strömberg.
Kategorier
Delphi is one of the top commercial law firms in Sweden. We help our clients with mergers and acquisitions. We advise them on matters of banking, finance and capital markets. We represent clients in court and in arbitration and are acknowledged as being extremely competent in public procurement, environmental law and real estate law.
Many of us are specialists in high-tech fields such as IT, intellectual property and life science. Our drive and our interest in technology and business probably explain, in part, our success. We are often praised for our commercial sense and our ability to understand the client’s business.
Our clients are to be found primarily in Scandinavia, Europe and North America. We also co-operate with law firms globally and regularly assist clients on international matters. We have a total workforce of approximately 185, of which more than 120 are lawyers. We have offices in Stockholm, Göteborg, Malmö, Linköping and Norrköping. Read more at www.delphi.se
